We suggest that during the premalignant stage of OSCC development, namely, OPMD, putative cancer cells become progressively immortalised by the inactivation of both TP53 and CDKN2A and the activation of telomerase. The gene discussed is CDKN2A; the disease is oculopharyngeal muscular dystrophy.